A solid-phase transfection platform for arrayed CRISPR screens.

Özdemirhan Serçin,Balca R Mardin,Aliaksandr Halavatyi,Katrin Rein,Paris Roidos,Amir Abdollahi,Sabine Reither,Thomas Muley,Maria Llamazares,Hauke Winter,Anna Baginska,Nadja Ballin,Frank T Zenke,Spyridon Palikyras,Beate Neumann,Renata Z Jurkowska

doi:10.15252/msb.209611

Abstract

Since the publication of this study, it has come to our attention that a citation to the study by Bulkescher et al (2017) was omitted from the Introduction. The following sentence should have been included in the introduction: “A previously reported solid‐phase reverse transfection method for proteins (Bulkescher et al , 2017) was used for the delivery of RNPs for three endogenous genes suggesting the potential of solid‐phase reverse transfection for CRISPR/Cas9‐based gene editing, despite its low efficiency”. We apologise for any inconvenience this omission may have caused.

Highlights

Since the publication of this study, it has come to our attention that a citation to the study by Bulkescher et al (2017) was omitted from the Introduction
The following sentence should have been included in the introduction: “A previously reported solid-phase reverse transfection method for proteins (Bulkescher et al, 2017) was used for the delivery of RNPs for three endogenous genes suggesting the potential of solid-phase reverse transfection for CRISPR/Cas9-based gene editing, despite its low efficiency”